Pharmafile Logo
Pharmafocus logo
Advanced Search

J&J buys into Genmab cancer drug

August 31, 2012
Sales and Marketing Cancer, Genmab, Janssen Cilag, Janssen-Cilag, Johnson & Johnson, multiple myeloma

Danish biotech company Genmab has sold the worldwide rights for one of its cancer drugs to Johnson & Johnson-owned Janssen …

News
GSK Stevenage

ABPI worried by public ignorance about medicines

August 31, 2012
Sales and Marketing ABPI, UK

People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …

News

Publicis creates new digital agency Razorfish Healthware

August 31, 2012
Medical Communications Razorfish Healthware, advertising, digital, publicis

 Two Publicis agencies, Razorfish Health and Publicis Healthware International are to be merged to create Razorfish Healthware, which will focus …

News

CPC Healthcare joins Indigenus network

August 31, 2012
Medical Communications CPC Healthcare Communications, CementBloc, Indegenus, Indigenus

CPC Healthcare Communications, based in Toronto, Canada, has joined Indigenus, the global network of independent healthcare agencies.The Indigenus network spans …

News

Patient death halts BMS hep C trial

August 30, 2012
Sales and Marketing BMS, HCV, hepatitis C

Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …

News

Genzyme ‘confident’ of FDA nod for MS drug

August 29, 2012
Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis

Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …

News

Efient fails to prove superiority to Plavix

August 29, 2012
Brillinta, Efient, Plavix, prasugrel, ticagrelor

Daiichi Sankyo and Lilly’s heart drug Efient has failed to come up to the mark in a late-stage trial which …

News

Innovation scorecard gets ABPI thumbs-up

August 29, 2012
Sales and Marketing NHS, NICE, market access

 An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …

News
Pascal Soirot takes over in October

AstraZeneca poaches Soirot from Roche to be new chief executive

August 28, 2012
Sales and Marketing AstraZeneca, Soirot

AstraZeneca has poached Roche’s head of pharma, Pascal Soriot, to be its new chief executive. He joins on 1 October. …

News

Novartis’ myelofibrosis treatment approved in Europe

August 28, 2012
Sales and Marketing Incyte, Jakavi, Novartis, Orphan Drugs, myelofibrosis

Novartis’ Jakavi, a new treatment for patients with myelofibrosis has been approved in Europe. The drug was co-developed with Incyte, …

News

GMP certification bodes well for Alexza’s lead product

August 28, 2012
Manufacturing and Production Alexza, FDA, GMP, schizophrenia

US drugmaker Alexza Pharmaceuticals’ manufacturing facility for lead product Adasuve has been given a green light from the Spanish medicine …

News

EMA warns of sterility issues with DepoCyte

August 28, 2012
Manufacturing and Production DepoCyte, Depocyt, Pacira, pharma recalls

The European Medicines Agency has issued a warning to US drugmaker Pacira Pharmaceuticals over manufacturing deficiencies at the plant making …

News

Pharma manufacturing news in brief

August 28, 2012
Manufacturing and Production Agennix, Bilcare, United Drug, West Pharmaceutical Services B. Braun Group

Agennix trial failure affects Lonza and DSM, United Drug buys Bilcare ops, plus facility news from West Pharma and B. …

News

Bosch gets bigger in India; unveils new capsule filler

August 28, 2012
Manufacturing and Production Bosch, India

Bosch Packaging Technology has expanded its presence in India with the opening of a new facility in Goa to help …

News

Ethical dilemmas add to ‘critical weaknesses’ In FDA safety monitoring

August 25, 2012
Sales and Marketing Avandia, Post-marketing surveillance, pharmacovigilance

Ethical challenges are central to continuing “critical weaknesses” in the FDA’s drug safety monitoring, according to a commentary by former …

News
lilly_corporate_hq

Lilly’s Alzheimer’s drug fails in phase III

August 24, 2012
Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab

 Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …

News

Indian reps strike over pharma’s bad ethics

August 24, 2012
Sales and Marketing FMRAI, India, pharma, reps

Pharma reps in India have gone on strike to highlight what they see as the corrupt nature of the pharma …

News

NHS must tackle ‘tsunami of bureaucracy’

August 24, 2012
Sales and Marketing CCGs, Farrar, NHS, reforms

The NHS Confederation has expressed concerns that the government’s reform of the health service will lead to a ‘tsunami of …

News
Pfizer image

Pfizer and Mylan sign Japanese generics deal

August 23, 2012
Sales and Marketing Mylan, Pfizer, generics

Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …

News
Novartis image

Novartis’ Indian patent case delayed

August 23, 2012
Sales and Marketing Glivec, MSF, Novartis, generics

Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026